Universal Biosensors Inc (ASX:UBI)
A$ 0.11 -0.005 (-4.35%) Market Cap: 32.79 Mil Enterprise Value: 23.82 Mil PE Ratio: 0 PB Ratio: 1.64 GF Score: 24/100

Half Year 2023 Universal Biosensors Inc Earnings Call Transcript

Aug 08, 2023 / 01:00AM GMT
Release Date Price: A$0.27 (+17.39%)
Unidentified Participant

Thank you for standing by, and welcome to the Universal Biosensors investor webinar and Q&A following recent results announced by the company. Please note that the presentation being used today has been lodged with the ASX. (Operator Instructions) And also, please note that this session is being recorded and can be heard afterwards.

On behalf of Universal Biosensors today we have CEO, John Charman. John, I'll hand it over to you. Please go ahead.

John Charman
- CEO, Chairman

Thanks, Matt, and good morning, everyone. Thanks for your attendance and for your ongoing interest. So this is a an update as to our H1 2023 performance, and it's worthy of having a recap. Early in 2020, UBI had one product in market. In the last 2.5 years, we've developed another nine products and we have 10 revenue generating assets delivering millions of test strips to thousands of customers around the world.

As we sit here today, we have $16.6 million of cash reserves. Our R&D rebate is expected to be another $4.5 million, and we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot